![](/img/cover-not-exists.png)
Pediatric Safety Evaluation of An AS-Adjuvanted H5N1 Prepandemic Candidate Vaccine in Children Aged 3–9 Years: A Phase II Study
A. Ballester, M. Garcés-Sánchez, M.V. Planelles Cantarino, M. Dramé, N. Bouveret, P. Gillard, J. Díez-DomingoVolume:
12
Year:
2008
Language:
english
DOI:
10.1016/j.ijid.2008.05.364
File:
PDF, 54 KB
english, 2008